Syros Pharmaceuticals, Inc.

5.43 USD
-0.02 (-0.37%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Syros Pharmaceuticals, Inc. stock is up 15.04% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 7 May’s closed higher than April. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Apr 13:49 18 Oct, 2024 2.50 CALL 86 1
09 Apr 13:52 18 Oct, 2024 2.50 CALL 200 1

About Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc. focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically defined subset of patients with myelodysplastic syndrome.